SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001618835-23-000008
Filing Date
2023-02-15
Accepted
2023-02-15 16:00:21
Documents
7
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A march2023preliminaryproxy.htm DEF 14A 188426
2 image5.jpg GRAPHIC 5711
3 image6.jpg GRAPHIC 4678
4 image7.jpg GRAPHIC 5200
5 jayfilesignature.jpg GRAPHIC 31976
6 page49_01xe2.jpg GRAPHIC 5706
7 pg3_saundraxsig.jpg GRAPHIC 92109
  Complete submission text file 0001618835-23-000008.txt   390187
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36754 | Film No.: 23635303
SIC: 2834 Pharmaceutical Preparations